Robbins Arroyo LLP Is Investigating the Officers and Directors of United Therapeutix Corporation (UTHR) on Behalf of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of United Therapeutics Corporation UTHR breached their fiduciary duties to shareholders. United Therapeutics, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases worldwide.

View this information on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/united-therapeutics-corporation

United Therapeutics Reveals Details of Potential Settlement

On July 27, 2017, United Therapeutics disclosed that it set aside $210 million for a possible settlement related to an investigation by the U.S. Department of Justice involving the company's donations to nonprofit organizations that give patients financial assistance to pay their out-of-pocket drug expenses. The investigation concerns whether these financial contributions violate the Federal Anti-Kickback Statute and the Federal False Claims Act. United Therapeutics further revealed that it is prepared to enter into a corporate-integrity agreement with the federal government that may obligate the company to comply with certain business practices for a number of years.

United Therapeutics Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leonid Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.

Attorney Advertising. Past results do not guarantee a similar outcome.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170803006391/en/